Allogene Therapeutics inked a research collaboration deal with Stanford University to work on a novel nucleic acid delivery system for CAR-T therapy.
Healthline Media and the National Alliance on Mental Illness announced the winners of the Healthline Stronger Scholarship, which is awarded to four university students around the U.S. for their commitment to academic and professional pursuits in mental health.
With the opioid crisis gripping the United States, many doctors have been looking at alternate treatments to help patients with long-term chronic pain. A new study shows that the venom from a scorpion sting could provide a solution.
Tubingen, Germany-based CureVac entered a collaboration research agreement with Yale University to focus on lung therapies.
Researchers say universities across the United States have been slow to adopt anti-tobacco policies on campuses despite public health efforts to curb tobacco use, especially among teens and young adults.
Three U.S. senators introduced a resolution in support of a moratorium and other limits on gene editing embryos.
There is a ban on conducting experiments on real human embryos after 14 days of growth, and researchers at Rockefeller University appear to have found a way to work around that ethical limitation.
Concern about clinical trial transparency, or more accurately the lack of transparency, is an ongoing problem. A new report shows that the lack of transparency also extends to post-marketing commitments that companies agreed to, following regulatory approval of a drug.
GlaxoSmithKline struck a research deal with the early pioneers of a prominent gene-editing technology at the University of California.